Market revenue in 2023 | USD 0.1 million |
Market revenue in 2030 | USD 0.2 million |
Growth rate | 11.3% (CAGR from 2023 to 2030) |
Largest segment | Single channel |
Fastest growing segment | Dual Channel |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Single Channel, Dual Channel |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Single channel was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Philippines deep brain stimulation devices market based on single channel, dual channel covering the revenue growth of each sub-segment from 2018 to 2030.
Philippines is one of the rapidly growing economies in Asia Pacific region due to the increase in healthcare spending. Furthermore, a study was conducted by Elsevier (information and Analytics Company) for evaluating the benefits of deep brain stimulation devices such as neurostimulators in patients suffering from PD.
It was observed that utilization of deep brain stimulation resulted in a statistically significant reduction of Unified Parkinson's Disease Rating Scale (UPDRS). Moreover, Philippines has a supportive medical community that cares for epilepsy patients and organizes awareness programs.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account